NextGen sequencing revealed that M14-BMR harbor a MAP4K1 (P422Q) mutation that has also been identified in a melanoma patient (cBioportal website), and the residue is adjacent to a critical serine phosphorylation site (S421; PhosphoSite). This evidence concerns the gene MAP4K1 and melanoma.